SBFM Projected Dividend Yield
Com Par $0.001 July 2024/Sunshine Biopharma Inc. ( NASDAQ : SBFM )Sunshine Biopharma is a pharmaceutical company. Co.'s proprietary drug development activities are focused on the development of a small molecule called Adva-27a for the treatment of aggressive forms of cancer. Co.'s Canadian wholly owned subsidiary, Sunshine Biopharma Canada Inc. has licensing agreements with a primary pharmaceutical company for four prescription generic drugs for the treatment of breast cancer, prostate cancer and enlarged prostate. These four generic products are Anastrozole, Letrozole, Bicalutamide, and Finasteride. Co. develops Essential 9™, a dietary supplement comprised of the nine amino acids which the human body cannot synthesize. 20 YEAR PERFORMANCE RESULTS |
SBFM Dividend History Detail SBFM Dividend News SBFM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |